Panultra D 30mg/40mg Capsule
By Panultra D
Rx
10 Capsule in a Strip

Composition
Domperidone(30mg) + Pantoprazole(40mg)

Manufacturer - Erzek Pharmaceuticals Pvt Ltd
B-21, BF, GUPTA COMPLEX OLD ROHTAK ROAD INDER LOK NEW DELHI New Delhi DL 110035 IN

Expires on or after
October, 2025

liver
Panultra D 30mg/40mg Capsule is considered safe for use in individuals with liver disease. Available data indicates that adjusting the dose of Panultra D 30mg/40mg Capsule may not be necessary for patients with liver issues. It is advisable to consult with your healthcare provider for personalized guidance on the use of this medication.

kidney
Panultra D 30mg/40mg Capsule requires caution in patients with kidney disease. Dosage adjustments may be necessary. Consult your doctor regarding kidney-related concerns.

alcohol
When taking Panultra D 30mg/40mg Capsule, be cautious when consuming alcohol. It is recommended to consult with your doctor regarding the use of alcohol.

driving
When taking Panultra D 30mg/40mg Capsule, it may reduce alertness, impact vision, or induce drowsiness and dizziness. Refrain from driving if experiencing these effects.

pregnancy
Panultra D 30mg/40mg Capsule may not be safe to use during pregnancy. Animal studies have shown harm to the developing baby. Your doctor will assess the benefits and risks before prescribing this medication. Please consult your doctor before using Panultra D 30mg/40mg Capsule.

breastfeeding
During breastfeeding, caution is advised when using Panultra D 30mg/40mg Capsule. It is recommended to delay breastfeeding until the mother has completed treatment and the drug is cleared from her system.
Habit Forming | No |
Chemical Class | - |
Therapeutic Class | GASTRO INTESTINAL |
Action Class | - |
₹120
Inclusive of all taxes
Content verified by

Dr. Gowri Kulkarni
MBBS - General Medicine, DNB - Psychiatry, MRCGP [INT] Family Medicine, BSIC (BACP)
Last update on 18-Nov-2024